Ver mas grande
BCL11B antibody
FT-FNab00838
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IP |
| Target | BCL11B |
| Research Area | Neuroscience, Metabolism, Developmental biology |
| Form | liquid |
| Recomended Dilution | WB: 1:200-1:1000 |
| Type Clonality | polyclonal |
| Immunogen | B-cell CLL/lymphoma 11B(zinc finger protein) |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | B-cell lymphoma/leukemia 11B (BCL-11B)|B-cell CLL/lymphoma 11B|COUP-TF-interacting protein 2|Radiation-induced tumor suppressor gene 1 protein (hRit1)|BCL11B|CTIP2|RIT1 |
| Host | Rabbit |
| UniProt ID | Q9C0K0 |
| Gene ID | 64919 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse |
| Observed MW | 116 kDa |
| Background | Tumor-suppressor protein involved in T-cell lymphomas. May function on the P53-signaling pathway. May be a key regulator of both differentiation and survival during thymocyte development. Repress transcription through direct, TFCOUP2-independent binding t |
Más información
BCL11B antibody